Kymera Therapeutics Inc.

NASDAQ: KYMR · Real-Time Price · USD
41.57
0.84 (2.06%)
At close: Aug 14, 2025, 3:59 PM
41.55
-0.04%
Pre-market: Aug 15, 2025, 08:59 AM EDT

Kymera Therapeutics Revenue

Kymera Therapeutics reported an annual revenue of $47.07M, reflecting a -40.11% growth. For the quarter ending June 30, 2025, Kymera Therapeutics generated $11.48M in revenue.
Revenue (ttm)
47.07M
Revenue Growth
-40.11%
Price / Sales Ratio
64.14
Revenue / Employee
226.31K
Employees
208
Market Cap
2.97B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.